Cargando…
Commentary: Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes - A multicenter retrospective study
Autor principal: | Gopal, Lingam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240490/ https://www.ncbi.nlm.nih.gov/pubmed/35326040 http://dx.doi.org/10.4103/ijo.IJO_648_22 |
Ejemplares similares
-
Initial experience in treating polypoidal choroidal vasculopathy with brolucizumab in Indian eyes – A multicenter retrospective study
por: Chakraborty, Debdulal, et al.
Publicado: (2022) -
Commentary: Pachydrusen in polypoidal choroidal vasculopathy in an Indian cohort
por: Anantharaman, Giridhar
Publicado: (2019) -
Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK
por: Ogura, Yuichiro, et al.
Publicado: (2022) -
Commentary: Managing treatment-resistant polypoidal choroidal vasculopathy – Evolving concepts
por: Agarwal, Divya, et al.
Publicado: (2022) -
One-year outcomes of intravitreal brolucizumab injections in patients with polypoidal choroidal vasculopathy
por: Ito, Arisa, et al.
Publicado: (2022)